Materno-fetal outcome was similar between N1 and N2, despite the fact that GH-IGF1 levels and somatotropinoma volume were statistically significantly higher in the N1 subgroup. This evidence concerns the gene GH1 and growth hormone-producing pituitary gland neoplasm.